Menu
Cell-Easy is a stem cell Contract Development and Manufacturing Organization (CDMO) that provides quick and easy access to ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects.
Their production process has been optimized under cGMP conditions and inspected by the French National Agency of Medicine and Health Products Safety (ANSM), in order to be scalable and guarantee optimal product safety, quality and efficacy for patients.
Venture Capital
Current
Europe
Financing round - Series A
Pharma Services
2020
Status
Creation Date
Number of Employees
Investment Date
Fund Name
